altRX Tirzepatide Review: Cost, Brand Access & Honest Verdict (2026)

altRX is a dual-modality telehealth platform offering compounded GLP-1s plus multiple brand-name FDA-approved options — this review directly verified Ozempic, Wegovy, and Zepbound present on the site, one of the broader brand-name lineups in this category, though Mounjaro specifically wasn't found. Every fact here comes from the company's own published program.

What altRX is

AltRX is a LegitScript Certified telehealth platform, offering compounded tirzepatide alongside multiple brand-name FDA-approved GLP-1s — this review directly confirmed Ozempic, Wegovy, and Zepbound present on the site; prior research also recorded Mounjaro as part of the lineup, though this review's own pass didn't independently locate it on the pages checked. Confirm the full brand roster directly with altRX.

What altRX costs

Compounded tirzepatide starts at $249/month — a starting-dose figure. AltRX publishes all-inclusive pricing across its product tiers, with consult, prescription, and shipping folded into the price with no stated hidden fees.

The brand-vs-compounded question

AltRX offers both routes: compounded tirzepatide and brand-name options including confirmed Ozempic, Wegovy, and Zepbound. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials, while the brand products are. See our Zepbound cost and savings guide for the branded benchmark.

How the care model holds up

AltRX's real strengths, and: broad brand-name access, a LegitScript Certified seal, published FDA compounded-medication disclaimer, transparent pricing across product tiers, and all-inclusive pricing with no stated hidden fees. The trade-offs: states served aren't disclosed; the 503A/503B compounding pharmacy partner isn't named, referred to only as "multiple USA-certified pharmacies"; no named medical director; and the corporate physical address isn't disclosed. As with any GLP-1 program, confirm your state's availability and which specific brand products are currently offered; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

AltRX's brand-name access and transparent, all-inclusive pricing are genuine strengths, but its compounding pharmacy and medical director remain unnamed. If you want named pharmacy partners alongside brand access, compare it against AlyveRx; if per-dose, no-subscription purchasing appeals to you instead, weigh Arc-1 — just read the fine print on how its price climbs by dose. See our best tirzepatide providers ranking for the full field.